CellDynamics iSrl
- Company typePrivate
- Founded2013
- HeadquartersBologna, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
CellDynamics iSrl firmographics
Firmographics- Name
- CellDynamics iSrl
- Legal name
- CellDynamics ISRL
- Website
- https://celldynamics.it
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
CellDynamics iSrl industry classification
Industry- Product category
- Laboratory Instrumentation for 3D Cell Analysis
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ), Organoids & Organ-on-Chip (regenerative models) (HLAAAGAD)
Keywords
Where CellDynamics iSrl is headquartered
LocationHeadquarters
- HQ city
- Bologna
- HQ country
- Italy
- HQ region
- Europe
Offices4 records
Markets served
CellDynamics iSrl business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- W8 Hardware and Software Sales: CellDynamics designs, develops, produces, and markets the W8 instrument and associated software entirely in-house. Revenue is generated from the sale of the W8 platform to pharma, biotech, and academic research institutions for biophysical characterization of 3D cell models.
- CELLviewer Platform: The CELLviewer lab-on-chip system is offered as part of the company's product portfolio for nutraceutical functional testing applications, targeting researchers and companies in the food/nutraceutical sector.
- PODA-3D Platform (in development): The PODA-3D project aims to deliver certified prototypes and advanced software for automated 3D cell model testing, intended for industrial implementation in pharma drug development workflows.
- RNA Therapeutic Testing Services (CN3_S9_BAC_04): Advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments, developed in collaboration with IFOM Institute.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | W8 Instrument — Enterprise Research Equipment |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
CellDynamics iSrl product offering
Product offeringCore offering
CellDynamics iSrl designs, develops, produces, and markets the W8, an automated laboratory instrument that performs non-disruptive, label-free, real-time biophysical quantification (size, mass density, weight) of live 3D cell cultures (spheroids and organoids) at a throughput of 20 organoids per hour. The company also offers the CELLviewer lab-on-chip platform for 3D organoid culture management, monitoring, and nutraceutical compound testing, with all fluidics, optics, and image-based software analysis developed in-house.
Product overview
CellDynamics iSrl offers a suite of innovative laboratory tools that synergize fluidics, optics, and sophisticated image-based software analysis for 3D cell model quantification. The core product portfolio consists of the W8 instrument, which provides automated structural quantification of 3D cell cultures through image-based analysis measuring size, mass density, and weight; and the CELLviewer platform, which enables 3D cell culture management, monitoring, and characterization for drug testing applications. Both products work together to enhance the utility of 3D cell cultures in disease modeling, drug testing, and tissue engineering by providing quantitative biophysical data.
Differentiator
Problem solved
Functional benefit
Products and services
- W8 Laboratory Instrument The W8 is an automated laboratory instrument that provides non-disruptive, label-free, sterile structural quantification of 3D cell models (organoids and spheroids) by measuring size (µm), mass density (fg/µm³), and weight (ng) at a throughput of 20 organoids per hour. Designed for samples ranging from 100–600 µm, the W8 enables sample recovery by size, mass density, or combined measurement for downstream analyses such as deep imaging, confocal microscopy, and drug testing. It is targeted at pharmaceutical and biotechnology research groups, academic and university research laboratories, and oncology centers conducting drug discovery, potency testing (IC50), compound permeation screening, and 3D cell model quality control.
- CELLviewer Platform CELLviewer is a lab-on-chip technological platform for 3D cell culture management, growth monitoring, and characterization of organoids and spheroids, designed to standardize and improve reliability in drug testing and nutraceutical functional testing. It integrates with organoid culture workflows, with applications focused on intestinal, hepatic, and trophoblast organoid models, and supports advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments.
Quantifiable outcome
- Throughput of 20 organoids per hour for fully automated biophysical characterization, with sample recovery for downstream analysis
- +4 more outcomes
Companies that use CellDynamics iSrl
Customer profileNamed customers12 records
Segments3 records
Ideal customer profiles3 records
CellDynamics iSrl technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
CellDynamics iSrl partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- TwinHelixcoreTwinHelix serves as the exclusive distribution partner for CellDynamics in Italy. Contact: Emanuela Ariotti ([email protected]).
- AltiumcoreAltium serves as the distribution partner for CellDynamics across the USA — covering the Boston Area (Zachary Taylor), California (Molly Clement), and Texas (Sean Doctor).
- PARALAB BIOcorePARALAB BIO serves as the distribution partner for CellDynamics in Spain and Portugal. Contact: Tel +34 94 603 5765, [email protected].
- SWIFT AnalyticalcoreSWIFT Analytical serves as the distribution partner for CellDynamics in the UK. Contact: Mebs Serve ([email protected]).
- NEW CELL XcoreNEW CELL X serves as the distribution partner for CellDynamics in France. Contact: Carole Bou Chrouch ([email protected]).
- 9X Biosciences (Shanghai) Co., Ltd.core9X Biosciences serves as the distribution partner for CellDynamics in China. Contact: Dr. Jun Huang ([email protected]).
- MITO KOGYOcoreMITO KOGYO serves as the distribution partner for CellDynamics in Japan. Contact: Ryuzo Narita ([email protected]).
- AlphaChromcoreAlphaChrom serves as the distribution partner for CellDynamics across Slovenia, Croatia, Kosovo, and Bosnia (Ines Topalovic Pitesa), and Serbia, Macedonia, and Montenegro (Milorad Ivetic & Anja Radakovic).
- PerlancorePerlan serves as the distribution partner for CellDynamics in Poland. Contact: Joanna Zimniak ([email protected]).
- Izasa ScientificcoreIzasa Scientific serves as an additional distribution partner for CellDynamics in the Iberian region (Spain). Contact: Silvia Fernandez Soriano ([email protected]).
- IFOM Institute (Istituto di Ricerca e Cura Cancer Campus)coreIFOM Institute is a strategic partner in the CN3_S9_BAC_04 project, conducting experimental work on 3D cell cultures and RNA therapeutics. CellDynamics leads the technological and algorithmic development while IFOM provides experimental biology capabilities for PDAC spheroid models and ASO drug testing.
- University of CataniacoreUniversity of Catania is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration uses botanical extracts from the Mount Etna region in Sicily.
- University of SassaricoreUniversity of Sassari is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration also focuses on botanical extracts from Sardinia, including those recovered from agri-food waste.
- PODA-3D Consortium (Implied Collaboration)minorPODA-3D is a multi-institutional precision oncology project that integrates automated liquid handling systems with CellDynamics' W8 technology for standardized 3D tumor model drug testing. Focus areas include breast cancer and glioblastoma spheroids.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
CellDynamics iSrl competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Thermo Fisher offers a comprehensive portfolio of life-science instruments, imaging systems, and cell analysis tools. While not focused on organoid mass density specifically, it competes broadly for the same pharma/biotech instrumentation budgets CellDynamics targets.
- Molecular Devices: Molecular Devices (Danaher) provides high-content imaging and screening instruments used for 3D cell culture and organoid analysis. It is a broader incumbent with overlapping biophysical/imaging functionality but a much larger pharma/biotech installed base.
- Sartorius: Sartorius supplies cell analysis instruments, bioreactors, and lab automation tools for biopharma R&D and manufacturing. It overlaps with CellDynamics in cell-based analytics and 3D cell culture workflow enablement, but as part of a much broader portfolio.
- PerkinElmer (Revvity): Revvity (formerly PerkinElmer) provides cell imaging, high-content analysis, and lab automation used in 3D cell culture and organoid research. It overlaps with CellDynamics' pharma/biotech customer base and could expand into biophysical QC features for spheroids/organoids.
Direct peers
- Emulate: Emulate develops organ-on-chip platforms (Liver-Chip, Lung-Chip) for predictive 3D cell modeling and drug response profiling. Like CellDynamics, Emulate operates at the intersection of microfluidics, organoid/3D culture, and pharma drug discovery applications.
- CN Bio: CN Bio offers PhysioMimix organ-on-chip systems for microphysiological 3D cell culture, drug metabolism, and toxicity testing. Both CellDynamics and CN Bio compete for pharma research dollars aimed at replacing 2D culture with standardized 3D/organoid workflows.
- Mimetas: Mimetas develops the OrganoPlate, a microfluidic organ-on-chip platform for 3D cell culture and organoid-based drug screening. It is the closest functional peer to CellDynamics' CELLviewer lab-on-chip system, addressing overlapping pharma/biotech customers with standardized 3D model workflows.
- InSphero: InSphero provides 3D spheroid and organoid technology platforms, including assay-ready microtissues and characterization tools for drug discovery. Like CellDynamics, InSphero targets pharma/biotech customers seeking standardization and QC of 3D cell models.
Emerging players
- Cellesce: Cellesce specializes in the expansion and production of organoids at scale for drug discovery and research applications. It is an emerging player in the broader 3D cell culture / organoid ecosystem that intersects with CellDynamics' customer base and standardization value proposition.
- CytoSMART: CytoSMART (now part of Axion Biosystems) develops compact live-cell imaging devices for cell culture monitoring. It overlaps with CellDynamics in live-cell, label-free monitoring of 3D cultures but focuses on more accessible benchtop formats.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CellDynamics iSrl social profiles
Digital presenceCellDynamics iSrl financial estimates
Financial estimateRevenue estimate
Valuation estimate
CellDynamics iSrl leadership team
Management profileNumber of profiles
CellDynamics iSrl funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CellDynamics iSrl M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CellDynamics iSrl
What does CellDynamics iSrl do?
CellDynamics iSrl designs, develops, produces, and markets the W8, an automated laboratory instrument that performs non-disruptive, label-free, real-time biophysical quantification (size, mass density, weight) of live 3D cell cultures (spheroids and organoids) at a throughput of 20 organoids per hour. The company also offers the CELLviewer lab-on-chip platform for 3D organoid culture management, monitoring, and nutraceutical compound testing, with all fluidics, optics, and image-based software analysis developed in-house.
Is CellDynamics iSrl a public or private company?
CellDynamics iSrl is a private company. It is classified as unknown and is currently operating.
When was CellDynamics iSrl founded?
CellDynamics iSrl was founded in 2013. It employs 11 to 50 people.
Where is CellDynamics iSrl based?
CellDynamics iSrl is headquartered in Bologna, Italy, in the Europe region.
How does CellDynamics iSrl make money?
Four revenue lines are on record. W8 Hardware and Software Sales are the primary driver. The others are CELLviewer Platform, PODA-3D Platform (in development) and RNA Therapeutic Testing Services (CN3_S9_BAC_04).
Who are CellDynamics iSrl's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Molecular Devices, Sartorius and PerkinElmer (Revvity). Direct peers are Emulate, CN Bio, Mimetas and InSphero. Emerging players are Cellesce and CytoSMART.
Does CellDynamics iSrl have an API?
No public API is recorded for CellDynamics iSrl.
What industry is CellDynamics iSrl in?
CellDynamics iSrl's product category is Laboratory Instrumentation for 3D Cell Analysis. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAAAIAJ, In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems). Its NAICS code is 334516 and its SIC code is 3826.